FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in Guangdong, China

Biotech startups in Guangdong, China

Updated 16 Nov 2026

Reset
Biotech startups in Guangdong, China
One-time CSV
  • 207 funded companies, 129 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~guangdong-china.csv207 rows × 18 columns
CompanyCityLast roundAmountDate
Shanmu SHANMUShenzhenSeries A$14.7M2026-05-06
Hongxin BiologyShenzhenSeries B$14.0M2026-08-13
Artivila TherapeuticsShenzhenSeries A$14.7M2026-06-23
MedefaZhuhaiSeries B$14.9M2026-09-02
Salus BioMedShenzhenSeries B$7.0M2025-10-09
XbiomeShenzhenSeries B$100.0M2021-12-22
EurekaBioShenzhenSeries B$41.7M2024-02-21
VivolightNanshanquSeries E$13.9M2026-06-01

8 rows of the CSV in 5 of its 18 columns.

207
Startups
$4.8B
Total raised
47
Funded in the last 12 months
$544.2M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

14 of 207
14 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Medefa Medefa uses synthetic biology to mass-produce novel PHA biomaterials. Biotech Zhuhai Series B $14.9M 2026-09-02 $16.3M Motianshi Touzi, Taiping Innovation 11 to 50 2019
Hongxin Biology Hongxin Biology develops mRNA drugs and delivers nucleic acid therapeutics to patients. Biotech Shenzhen Series B $14.0M 2026-08-13 $14.0M Haiyuan Capital, Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group 11 to 50 2021
Shengqiang Technology Shengqiang Technology researches, manufactures, and sells high-tech products. Biotech Shenzhen Series C $13.7M 2026-07-26 $13.7M SDIC Venture Capital 101 to 250 2013
Artivila Therapeutics Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. Artificial intelligence Shenzhen Series A $14.7M 2026-06-23 $53.3M Highlight Capital, Med-Fine Capital, Hike Capital +2 11 to 50 2018
Vivolight Vivolight conducts medical research and develops intravascular interventional imaging technology. Biotech Nanshanqu Series E $13.9M 2026-06-01 $52.2M CAS Star, TusStar 51 to 100 2012
Shanmu SHANMU Shanmu develops micro medical robots using digital microfluidic chipsets and artificial intelligence algorithms. Artificial intelligence Shenzhen Series A $14.7M 2026-05-06 $16.0M QF Capital, Hofan Venture, Wanwu Capital +1 1 to 10 2020
Ningkang Ruizhu Ningkang Ruizhu develops targeted drugs. Biotech Zhuhai Series A $14.1M 2025-12-05 $25.6M GF Qianhe Investment, RiverHead Capital, Hanne Capital +1 11 to 50 2019
Tianchen Biotechnology Tianchen Biotechnology develops and sells medical products for ophthalmology. Biotech Tianjin Series C $27.8M 2025-06-03 $41.7M CMB International Capital Corporation 2018
Zhiyi Pharmaceutics Zhiyi Pharmaceutics researches and develops second-generation probiotics and live biotherapeutics. Biotech Guangzhou Series C $13.8M 2024-03-28 Shenzhen Capital Group, SDIC Venture Capital, Sinoking Capital 51 to 100 2013
Enzymecode Biotechnology Enzymecode develops and produces brain health nutritional raw materials and food ingredients. Biotech Tianjin Angel $1.4M 2023-12-29 Draper Dragon 11 to 50 2017
Yuanyi Biotech Yuanyi Biotech creates artificial microbial technologies and products. Biotech Tianjin Series A $13.7M 2023-10-18 $21.5M Marathon Venture Partners, Haitang Fund, Ruipeng Touzi 51 to 100 2021
Canton Biologics Canton Biologics provides biologics contract development and manufacturing outsourcing services. Biotech Guangzhou Series C $41.3M 2023-09-13 $41.7M SDIC Venture Capital, Rongtuo Capital Management, Taipu Life Sciences Investment 101 to 250 2016
Chipsailing Chipsailing Technology sells integrated circuits for fingerprint identification. Biotech Nanshanqu Series A $1.4M 2017-05-11 Oriental Fortune Capital, Haiyuan Capital 11 to 50 2015
iCarbonX Unicorn iCarbonX is a China-based company that builds artificial intelligence platforms for health data. Artificial intelligence Shenzhen Series A $45.0M 2016-07-15 $200.0M Share Capital, ProCapital 51 to 100 2015

Table 1. Biotech startups in Guangdong, China: the 14 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 207.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Medefa Medefa uses synthetic biology to mass-produce novel PHA biomaterials. Biotech Zhuhai Series B $14.9M 2026-09-02 $16.3M Motianshi Touzi, Taiping Innovation 11 to 50 2019
2 Artivila Therapeutics Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. Artificial intelligence Shenzhen Series A $14.7M 2026-06-23 $53.3M Highlight Capital, Med-Fine Capital, Hike Capital +2 11 to 50 2018
3 Shanmu SHANMU Shanmu develops micro medical robots using digital microfluidic chipsets and artificial intelligence algorithms. Artificial intelligence Shenzhen Series A $14.7M 2026-05-06 $16.0M QF Capital, Hofan Venture, Wanwu Capital +1 1 to 10 2020
4 Ningkang Ruizhu Ningkang Ruizhu develops targeted drugs. Biotech Zhuhai Series A $14.1M 2025-12-05 $25.6M GF Qianhe Investment, RiverHead Capital, Hanne Capital +1 11 to 50 2019
5 Hongxin Biology Hongxin Biology develops mRNA drugs and delivers nucleic acid therapeutics to patients. Biotech Shenzhen Series B $14.0M 2026-08-13 $14.0M Haiyuan Capital, Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group 11 to 50 2021
6 Vivolight Vivolight conducts medical research and develops intravascular interventional imaging technology. Biotech Nanshanqu Series E $13.9M 2026-06-01 $52.2M CAS Star, TusStar 51 to 100 2012
7 Shengqiang Technology Shengqiang Technology researches, manufactures, and sells high-tech products. Biotech Shenzhen Series C $13.7M 2026-07-26 $13.7M SDIC Venture Capital 101 to 250 2013

Table 2. Biotech startups in Guangdong, China: the 7 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 SDIC Venture Capital Venture capital firm Xicheng, China 3 1% 1 Shengqiang Technology
2 Oriental Fortune Capital Venture capital firm Shenzhen, China 3 1%
3 Haitang Fund Venture capital firm Nankai, China 3 1% 1 Zhonghe Gene
4 Kaitai Capital Venture capital firm Hangzhou, China 3 1%
5 Haiyuan Capital Venture capital firm Shenzhen, China 2 1% 1 Hongxin Biology
6 Shenzhen Capital Group Venture capital firm Nanshan, China 2 1%
7 Gaorong Capital Venture capital firm Wangjing, China 2 1%
8 Fortune Venture Capital Venture capital firm Shenzhen, China 2 1%
9 Shenzhen Guozhong Venture Capital Management Venture capital firm Shenzhen, China 2 1%
10 Yael Capital Management Limited Venture capital firm Shenzhen, China 2 1%
11 SZHTI Group Venture capital firm Shenzhen, China 2 1% 2 Newdel Biotech, JGene Biotechnology
12 Wanwu Capital Venture capital firm Beijing, China 1 0% 1 Shanmu SHANMU
13 Glacier Capital Investment bank Phoenix, United States 1 0% 1 Shanmu SHANMU
14 QF Capital Private equity firm Shenzhen, China 1 0% 1 Shanmu SHANMU
15 Hofan Venture Venture capital firm Shenzhen, China 1 0% 1 Shanmu SHANMU

Table 3. Biotech startups in Guangdong, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 174 84% $3.6B
Software 17 8% $662.1M
Artificial intelligence 16 8% $662.1M
Hardware 5 2% $30.6M
Energy 3 1% $816.8M
Cybersecurity 2 1%

Table 4. Biotech startups in Guangdong, China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Seed 64 31% $1.4M
Series A 69 33% $14.1M
Series B 39 19% $14.1M
Series C 29 14% $14.5M
Series D+ 6 3% $87.0M

Table 5. Biotech startups in Guangdong, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Shenzhen 98 47%
Guangzhou 52 25%
Tianjin 15 7%
Zhuhai 12 6%
Nanshanqu 6 3%
Huangpu 4 2%
Pingshan 3 1%
Zhangshan 3 1%
Nansha 2 1%
Foshan 2 1%
Panyu 2 1%
Luzhou 1 0%

Table 6. Biotech startups in Guangdong, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 3 6% $55.4M
September 2026 3 6% $104.3M
August 2026 7 15% $52.6M
July 2026 6 13% $28.5M
June 2026 4 9% $36.0M
May 2026 3 6% $29.4M
April 2026 2 4% $29.1M
March 2026 2 4% $164.5M
February 2026 2 4% $14.4M
January 2026 10 21% $15.7M
December 2025 3 6% $14.1M
November 2025 2 4%

Table 7. Biotech startups in Guangdong, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 42 20% $530.1M
2025 27 13% $279.5M
2024 24 12% $185.1M
2023 27 13% $252.8M
2022 24 12% $1.0B
2021 16 8% $442.4M

Table 8. Biotech startups in Guangdong, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 22 11%
2020 to 2022 44 22%
2015 to 2019 86 42%
2010 to 2014 30 15%
Before 2010 22 11%

Table 9. Biotech startups in Guangdong, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 13 8%
11 to 50 62 40%
51 to 100 40 26%
101 to 250 22 14%
251 to 500 10 6%
501 to 1,000 6 4%
1,001 to 5,000 1 1%

Table 10. Biotech startups in Guangdong, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Guangdong, China are on the list?
207, in the file dated 16 November 2026. 47 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 207 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in Guangdong, China: 207 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in Guangdong, China by funding stage

Other sectors in Guangdong

Biotech startups elsewhere

Cite: FundingWatcher, 207 funded biotech companies in Guangdong, China, 16 November 2026. https://fundingwatcher.com/startups/biotech/guangdong-china/